Application 210329
- Type
- ANDA
- Sponsor
- JUBILANT GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210329-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210329-001 | AB1 |
| A210329-002 | AB1 |
| A210329-003 | AB1 |
| A210329-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | 3ea7612b-b004-43ef-accc-34c8ec5146b8 | 2026-03-05 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | fee8c2be-ccfa-4c66-abed-5e232ec762ae | 2026-02-27 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| N/A | TADALAFIL | Bostal LLC | 78509a43-a907-4359-9022-f38c4f765880 | 2026-02-04 | Warnings, Adverse reactions | TADALAFIL |
| TADALAFIL | TADALAFIL | A-S Medication Solutions | cd94158b-43fa-44fc-a858-0983770efa83 | 2026-02-02 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | REMEDYREPACK INC. | 2121cd9b-a2c0-4f19-a33d-939c6fb3826d | 2026-01-20 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | AvKARE | b96ae7f1-7d4a-a211-e053-2995a90ab6e2 | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceutical,Inc. | 48850075-ac57-abb7-e063-6394a90a7881 | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals, Inc. | 48892acb-43bb-a4d8-e063-6394a90a5d61 | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Upsher-Smith Laboratories, LLC | ae801b15-0462-44af-99a4-affe3eed899a | 2026-01-16 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | affacb88-4af3-4ce9-961b-7fc37b169e9a | 2026-01-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | f34e4747-28be-4ae5-ac9a-a825083b6a9b | 2026-01-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 7e236f83-14bf-4862-91fb-74d766aef6a9 | 2026-01-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | cf353da9-31c6-66c2-e053-2995a90a3bb0 | 2026-01-09 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f3092f5a-b976-91ab-e053-2995a90a9b50 | 2026-01-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f317fe1e-d7c4-fb8b-e053-2a95a90a5445 | 2026-01-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | 0afd0728-256a-293b-e063-6394a90a3c5f | 2025-12-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Northwind Health Company, LLC | f2a132af-d75e-2ca0-e053-2a95a90a332e | 2025-12-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | 0ea97208-5afc-4943-b35c-ea850203a794 | 2025-12-19 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| ADCIRCA | TADALAFIL | United Therapeutics Corporation | ff61b237-be8e-461b-8114-78c52a8ad0ae | 2025-12-15 | Warnings, Adverse reactions | TADALAFIL |
| Tadalafil | TADALAFIL | NIVAGEN PHARMACEUTICALS, INC. | ca1d46e3-ad9b-48c7-bb7f-63ee678ccf7a | 2025-12-09 | Warnings, Adverse reactions | Tadalafil TADALAFIL |